Streamex Corp. Files Definitive Proxy Materials

TL;DR

Streamex Corp. (fka BioSig) filed proxy docs Nov 3, 2025. Check for shareholder updates.

AI Summary

Streamex Corp. filed a Definitive Additional Materials proxy statement on November 3, 2025. The company, formerly known as BioSig Technologies, Inc. until September 21, 2011, is headquartered at 2431 Aloma Avenue, Suite 243, Winter Park, FL 32792. The filing relates to the Securities Exchange Act of 1934.

Why It Matters

This filing indicates that Streamex Corp. is providing updated or additional proxy materials to shareholders, which may contain important information regarding upcoming shareholder votes or corporate actions.

Risk Assessment

Risk Level: low — This is a routine filing of proxy materials and does not inherently indicate significant new risks.

Key Players & Entities

• Streamex Corp. (company) — Registrant
• BioSig Technologies, Inc. (company) — Former company name
• 20110921 (date) — Date of name change
• 20251103 (date) — Filing date
• 2431 ALOMA AVENUE (address) — Business and mailing address
• SUITE 243 (address) — Business and mailing address
• WINTER PARK (address) — City
• FL (address) — State
• 32792 (address) — Zip code
• (203) 409-5444 (phone) — Business phone number

FAQ

Key Financial Figures

• $0.001 — ch registered Common Stock, par value $0.001 per share STEX The Nasdaq Stock Mar

Filing Documents

• formdefa14a.htm (DEFA14A) — 67KB
• 0001493152-25-020563.txt ( ) — 68KB

From the Filing

UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to §240.14a-12 STREAMEX CORP. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check all boxes that apply): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. UNITED SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2025 STREAMEX CORP. (Exact name of registrant as specified in its charter) Delaware 001-38659 26-4333375 (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 2431 Aloma Avenue, Suite 243 Winter Park, Florida 32792 (Address of principal executive offices) (Zip Code) (203) 409-5444 (Registrant's telephone number, including area code) N/A (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of exchange on which registered Common Stock, par value $0.001 per share STEX The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 7.01. Regulation FD Disclosure. On October 30, 2025, Streamex Corp. (f./k/a BioSig Technologies, Inc.), a Delaware corporation (the "Company") issued a press release announcing Nasdaq's approval for continued listing and providing details regarding the reconvened special meeting of stockholders. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein. The information in this Item 7.01 (including Exhibit 99.1) is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing. Item 8.01. Other Events. On October 30, 2025, in addition to the Company announcing that Nasdaq has granted formal approval for the continued listing of the Company's common stock on The Nasdaq Capital Market under the ticker symbol "STEX," announced that it will convene a special meeting of stockholders at 3:00 p.m. Eastern Time on November 4, 2025, to reconvene the previously adjourned Proposal 1 – the Acquisition Proposal, for formal vote and approval. The special meeting will be held via webcast at www.virtualshareholdermeeting.com/BSGM2025SM , and stockholders of record as of the applicable record date will be able to attend, vote and ask questions online during the meeting . Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release 104 Cover Page Interactive Data File (formatted as Inline XBRL) SIGNATU RES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. STREAMEX CORP. Date: October 31, 2025 By: /s/ Karl Henry McPhie Name: Karl Henry McPhie Title: Chief Executive Officer Exhibit 99.1 S

View Full Filing

View this DEFA14A filing on SEC EDGAR